
NYSE:PG
This summary was created by AI, based on 12 opinions in the last 12 months.
Experts express a cautionary view on Procter & Gamble (PG), highlighting challenges in the consumer sector amid rising input costs and economic uncertainties. While the company remains a reputable dividend aristocrat with a near 3% yield, many analysts are hesitant due to its recent 14.4% decline over the past year and the expectation of modest growth, which is around 4.5%. Despite these challenges, some experts view PG's robust brand portfolio as a strength, indicating that the stock may bounce back in the long term due to its defensive nature amid potential economic downturns. There is a sentiment that PG may be a solid buy as it trades at an attractive valuation, although considerable risks remain in the consumer staples sector, leading to a mixed outlook for substantial returns.
Best in breed, but it is a developed economy story. It is US centric and Canada centric. You buy this and put it away and give it to your grandkids. Also, gradually increases its dividend. Because of the decline in emerging market currencies, Unilever (UL-N) might be a better value option at this time.
Growth is still relatively strong, but the valuation is rather high. This one was considered safer growth. It is not particularly cheap. They will have to start doing acquisitions again to get growth. It is a problem for the consumer sector in general. He has no exposure to consumer retail / discretionary.
Great company and one that has excelled over the years, but trading at around 18X earnings right now. The consumer packaged space is really a slow growth space. If they can get 2%-3% revenue growth, they are happy. It just doesn’t support an 18 multiple. A lot of money has flowed into this because of an attractive dividend, but he would be a little bit concerned with the capital given the multiple and where it is.
The premier consumer product company. Good quality product. Exposed to the global market. Has been somewhat slow growing for the last few years. Organically their basically looking at low single digit growth. With cost-cutting and stock buyback, they may be able to get a 5%-8% upside per year, which he doesn’t think is enough for most portfolios. Longer-term, he doesn’t see anything wrong with it.
Had a few issues over the last little while. Large companies like this were all highlighted as to their ability to grow in China. China has been a lot more difficult to deal with than people thought. This has hurt the stock a little. All in all, it is a great company with great products and is not trading at a very high multiple. Global growth will help this company. Made a few changes, which will help them. Expecting better top line growth.
His model prices $78, a 7% downside. This is a large cap stock and is going to have a beta of 1, which means that if the market is going to be up 20%, this one will probably be up 20%. Doesn’t particularly like this one. There are other possibilities out there, but you are not going to get hurt either.
This has a very specific seasonal trend. It tends to do well from Aug 17 to Nov 19. It is a consumer staples stock, which tends to do well in that time frame period, when they’re transitioning out of the weaker summer months into the stronger winter months. This has done well, up until this point, but right now we are past that seasonal period. He would wait.